Richard E Lowenthal
CIK 1378550 · PRESIDENT AND CEO · last filed 2026-01-05
Richard E Lowenthal is a PRESIDENT AND CEO who has filed 32 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for SPRY, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$23.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $128.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$128.70M
2
32
-$23.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | PRESIDENT AND CEO | 13,186,389 | $9.76 | $128.70M | -$23.82M | 31 | 2026-01-05 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | VP | — | — | — | $0 | 1 | 2007-03-26 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-08-22 | SPRY | Sell (S) | −50,000 | -$724.3K | EDGAR |
| 2025-01-03 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-12-19 | SPRY | Sell (S) | −100,000 | -$1.17M | EDGAR |
| 2024-12-11 | SPRY | Sell (S) | −100,000 | -$1.32M | EDGAR |
| 2024-12-09 | SPRY | Exer (M) | +37,541 | $219.8K | EDGAR |
| 2024-11-21 | SPRY | Sell (S) | −100,000 | -$1.39M | EDGAR |
| 2024-11-14 | SPRY | Sell (S) | −100,000 | -$1.68M | EDGAR |
| 2024-10-17 | SPRY | Sell (S) | −100,000 | -$1.49M | EDGAR |
| 2024-10-10 | SPRY | Sell (S) | −100,000 | -$1.38M | EDGAR |